Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 118

1.

Upper digestive bleeding in cirrhosis. Post-therapeutic outcome and prognostic indicators.

D'Amico G, De Franchis R; Cooperative Study Group.

Hepatology. 2003 Sep;38(3):599-612.

PMID:
12939586
2.

The effectiveness of current acute variceal bleed treatments in unselected cirrhotic patients: refining short-term prognosis and risk factors.

Amitrano L, Guardascione MA, Manguso F, Bennato R, Bove A, DeNucci C, Lombardi G, Martino R, Menchise A, Orsini L, Picascia S, Riccio E.

Am J Gastroenterol. 2012 Dec;107(12):1872-8. doi: 10.1038/ajg.2012.313. Epub 2012 Sep 25.

PMID:
23007003
3.

Predictive factors for rebleeding and death in alcoholic cirrhotic patients with acute variceal bleeding: a multivariate analysis.

Krige JE, Kotze UK, Distiller G, Shaw JM, Bornman PC.

World J Surg. 2009 Oct;33(10):2127-35. doi: 10.1007/s00268-009-0172-6.

PMID:
19672651
4.

Improved survival after variceal bleeding in patients with cirrhosis over the past two decades.

Carbonell N, Pauwels A, Serfaty L, Fourdan O, Lévy VG, Poupon R.

Hepatology. 2004 Sep;40(3):652-9.

PMID:
15349904
5.

A predictive model for failure to control bleeding during acute variceal haemorrhage.

Ben-Ari Z, Cardin F, McCormick AP, Wannamethee G, Burroughs AK.

J Hepatol. 1999 Sep;31(3):443-50. Erratum in: J Hepatol 2001 Apr;34(4):640.

PMID:
10488702
6.

[Comparison of predictive factors related to the mortality and rebleeding caused by variceal bleeding: Child-Pugh score, MELD score, and Rockall score].

Lee JY, Lee JH, Kim SJ, Choi DR, Kim KH, Kim YB, Kim HY, Yoo JY.

Taehan Kan Hakhoe Chi. 2002 Dec;8(4):458-64. Korean.

7.

Prognostic indicators of successful endoscopic sclerotherapy for prevention of rebleeding from oesophageal varices in cirrhosis: a long-term cohort study.

Madonia S, D'Amico G, Traina M, Gatto G, Virdone R, Salamone N, Licata A, Tarantino I, Pagliaro L.

Dig Liver Dis. 2000 Dec;32(9):782-91.

PMID:
11215559
8.

Clinical features and treatment outcomes of upper gastrointestinal bleeding in patients with cirrhosis.

Seo YS, Kim YH, Ahn SH, Yu SK, Baik SK, Choi SK, Heo J, Hahn T, Yoo TW, Cho SH, Lee HW, Kim JH, Cho M, Park SH, Kim BI, Han KH, Um SH.

J Korean Med Sci. 2008 Aug;23(4):635-43. doi: 10.3346/jkms.2008.23.4.635.

9.

[A prospective study comparing the efficacy of early administration of terlipressin and somatostatin for the control of acute variceal bleeding in patients with cirrhosis].

Seo YS, Um SH, Hyun JJ, Kim YH, Park S, Keum BR, Kim YS, Jeen YT, Lee HS, Chun HJ, Lee SW, Choi JH, Kim CD, Ryu HS.

Korean J Hepatol. 2006 Sep;12(3):373-84. Korean.

10.

Treatment of active gastroesophageal variceal bleeding with terlipressin or hemostatic balloon in patients with cirrhosis. A randomized controlled trial.

García-Compeán D, Blanc P, Bories JM, Michel J, Desprez D, Pageaux GP, David XR, Larrey D, Michel H.

Arch Med Res. 1997 Summer;28(2):241-5.

PMID:
9204616
11.

Endoscopic treatment of esophagogastric variceal bleeding in patients with noncirrhotic extrahepatic portal vein thrombosis: a long-term follow-up study.

Spaander MC, Darwish Murad S, van Buuren HR, Hansen BE, Kuipers EJ, Janssen HL.

Gastrointest Endosc. 2008 May;67(6):821-7. doi: 10.1016/j.gie.2007.08.023. Epub 2008 Jan 18.

PMID:
18206153
12.

Octreotide compared with placebo in a treatment strategy for early rebleeding in cirrhosis. A double blind, randomized pragmatic trial.

D'Amico G, Politi F, Morabito A, D'Antoni A, Guerrera D, Giannuoli G, Traina M, Vizzini G, Pasta L, Pagliaro L.

Hepatology. 1998 Nov;28(5):1206-14.

PMID:
9794903
13.

Predicting early mortality after acute variceal hemorrhage based on classification and regression tree analysis.

Augustin S, Muntaner L, Altamirano JT, González A, Saperas E, Dot J, Abu-Suboh M, Armengol JR, Malagelada JR, Esteban R, Guardia J, Genescà J.

Clin Gastroenterol Hepatol. 2009 Dec;7(12):1347-54. doi: 10.1016/j.cgh.2009.08.011. Epub 2009 Aug 21.

PMID:
19699816
14.

Nonvariceal upper gastrointestinal bleeding in patients with liver cirrhosis. Clinical features, outcomes and predictors of in-hospital mortality. A prospective study.

González-González JA, García-Compean D, Vázquez-Elizondo G, Garza-Galindo A, Jáquez-Quintana JO, Maldonado-Garza H.

Ann Hepatol. 2011 Jul-Sep;10(3):287-95.

15.

Early administration of vapreotide for variceal bleeding in patients with cirrhosis.

Calès P, Masliah C, Bernard B, Garnier PP, Silvain C, Szostak-Talbodec N, Bronowicki JP, Ribard D, Botta-Fridlund D, Hillon P, Besseghir K, Lebrec D; French Club for the Study of Portal Hypertension.

N Engl J Med. 2001 Jan 4;344(1):23-8.

16.

Assessing the short- and long-term prognosis of patients with cirrhosis and acute variceal bleeding.

Sempere L, Palazón JM, Sánchez-Payá J, Pascual S, de Madaria E, Poveda MJ, Carnicer F, Zapater P, Pérez-Mateo M.

Rev Esp Enferm Dig. 2009 Apr;101(4):236-48. English, Spanish.

17.

Clinical trial: The effect of somatostatin vs. octreotide in preventing post-endoscopic increase in hepatic venous pressure gradient in cirrhotics with bleeding varices.

Vlachogiannakos J, Kougioumtzian A, Triantos C, Viazis N, Sgouros S, Manolakopoulos S, Saveriadis A, Markoglou C, Economopoulos T, Karamanolis DG.

Aliment Pharmacol Ther. 2007 Dec;26(11-12):1479-87. Epub 2007 Oct 5.

19.

Sclerotherapy with or without octreotide for acute variceal bleeding.

Besson I, Ingrand P, Person B, Boutroux D, Heresbach D, Bernard P, Hochain P, Larricq J, Gourlaouen A, Ribard D, et al.

N Engl J Med. 1995 Aug 31;333(9):555-60.

Supplemental Content

Support Center